Only in AD Scientific Index !!!!
Subject Rankings, University Subject Rankings, Citiation Rankings, i10 Productivity Rankings, Country Rankings, Detailed analyses of universities
AD Scientific Index - World Scientists Rankings - 2024 | H INDEX | i10 INDEX | CITATION | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
University / Institution |
Country | Region | World | Name | Country | University / Institution | Subject | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total |
2 | 1,431 | 1,536 | 3,092 |
|
United States | Johnson & Johnson Co. |
Others
|
129 | 51 | 0.395 | 288 | 177 | 0.615 | 54,447 | 11,670 | 0.214 |
4 | 5,974 | 6,528 | 13,116 |
|
United States | Johnson & Johnson Co. |
Others
|
88 | 69 | 0.784 | 110 | 103 | 0.936 | 82,001 | 49,605 | 0.605 |
5 | 6,939 | 7,580 | 15,392 |
|
United States | Johnson & Johnson Co. |
Others
medicine | kidney | |
85 | 34 | 0.400 | 195 | 107 | 0.549 | 24,129 | 4,385 | 0.182 |
6 | 7,588 | 8,291 | 16,919 |
|
United States | Johnson & Johnson Co. |
Others
Oncology Early Drug Development | |
82 | 62 | 0.756 | 317 | 195 | 0.615 | 36,393 | 18,968 | 0.521 |
8 | 12,920 | 14,284 | 30,416 |
|
United States | Johnson & Johnson Co. |
Others
|
69 | 43 | 0.623 | 156 | 108 | 0.692 | 25,793 | 10,896 | 0.422 |
12 | 25,414 | 28,449 | 65,400 |
|
United States | Johnson & Johnson Co. |
Others
|
53 | 35 | 0.660 | 103 | 80 | 0.777 | 7,859 | 3,579 | 0.455 |
13 | 25,676 | 28,751 | 66,220 |
|
United States | Johnson & Johnson Co. |
Others
Drug transporters | Drug-Drug Interactions | Enzyme Induction | Drug-Induced Liver Injury | ADME | |
53 | 30 | 0.566 | 87 | 60 | 0.690 | 16,688 | 4,093 | 0.245 |
16 | 29,305 | 32,885 | 77,254 |
|
United States | Johnson & Johnson Co. |
Others
Digital Health | Drug Development | Immune-Mediated Diseases | |
50 | 29 | 0.580 | 73 | 60 | 0.822 | 9,962 | 3,480 | 0.349 |
22 | 35,273 | 39,676 | 96,245 |
|
United States | Johnson & Johnson Co. |
Others
|
46 | 22 | 0.478 | 86 | 41 | 0.477 | 7,678 | 1,474 | 0.192 |
24 | 35,941 | 40,425 | 98,298 |
|
United States | Johnson & Johnson Co. |
Others
|
45 | 34 | 0.756 | 95 | 71 | 0.747 | 5,973 | 3,574 | 0.598 |
Click for INSTITUTIONAL REGISTRATION and PREMIUM MEMBERSHIP advantages |
||||||||||||||||
25 | 36,850 | 41,497 | 101,314 |
|
United States | Johnson & Johnson Co. |
Others
|
45 | 22 | 0.489 | 98 | 53 | 0.541 | 8,295 | 3,791 | 0.457 |
26 | 37,540 | 42,273 | 103,470 |
|
United States | Johnson & Johnson Co. |
Others
|
44 | 34 | 0.773 | 62 | 59 | 0.952 | 9,272 | 4,414 | 0.476 |
29 | 39,728 | 44,797 | 110,813 |
|
United States | Johnson & Johnson Co. |
Others
|
43 | 28 | 0.651 | 89 | 60 | 0.674 | 8,517 | 2,850 | 0.335 |
30 | 40,925 | 46,142 | 114,438 |
|
United States | Johnson & Johnson Co. |
Others
|
42 | 35 | 0.833 | 87 | 73 | 0.839 | 8,532 | 6,641 | 0.778 |
31 | 41,093 | 46,338 | 115,025 |
|
United States | Johnson & Johnson Co. |
Others
Schizophrenia | Neuroscience | Cardiovascular Disease | Pulmonary Disease | Rare Diseases | |
42 | 33 | 0.786 | 84 | 69 | 0.821 | 21,621 | 14,628 | 0.677 |
33 | 42,470 | 47,905 | 119,628 |
|
United States | Johnson & Johnson Co. |
Others
Research and Development | |
42 | 15 | 0.357 | 105 | 25 | 0.238 | 13,434 | 2,241 | 0.167 |
38 | 47,677 | 53,844 | 137,699 |
|
United States | Johnson & Johnson Co. |
Others
|
39 | 27 | 0.692 | 66 | 53 | 0.803 | 6,844 | 2,646 | 0.387 |
42 | 51,853 | 58,567 | 152,424 |
|
United States | Johnson & Johnson Co. |
Others
|
37 | 29 | 0.784 | 55 | 41 | 0.745 | 5,321 | 3,311 | 0.622 |
47 | 58,837 | 66,551 | 177,393 |
|
United States | Johnson & Johnson Co. |
Others
bioactivation | PBPK | |
35 | 16 | 0.457 | 46 | 27 | 0.587 | 4,274 | 840 | 0.197 |
54 | 64,320 | 72,787 | 197,424 |
|
United States | Johnson & Johnson Co. |
Others
Regenerative therapy | wound healing | lipid metabolism | retina | cell therapy | |
33 | 20 | 0.606 | 43 | 29 | 0.674 | 5,225 | 1,132 | 0.217 |
55 | 67,578 | 76,470 | 209,159 |
|
United States | Johnson & Johnson Co. |
Others
|
32 | 20 | 0.625 | 49 | 27 | 0.551 | 4,984 | 1,107 | 0.222 |
56 | 67,842 | 76,773 | 210,210 |
|
United States | Johnson & Johnson Co. |
Others
Vision | Aberration Theory | Optics | Astronomy | Algorithm | |
32 | 18 | 0.563 | 68 | 44 | 0.647 | 3,363 | 1,227 | 0.365 |
57 | 68,185 | 77,165 | 211,424 |
|
United States | Johnson & Johnson Co. |
Others
Drug Discovery | |
32 | 16 | 0.500 | 48 | 23 | 0.479 | 6,406 | 1,625 | 0.254 |
64 | 79,077 | 89,529 | 252,655 |
|
United States | Johnson & Johnson Co. |
Others
Medical Product Development | Surgical Skill Testing | Bio-mechanical Models | Medical database development | |
29 | 17 | 0.586 | 45 | 28 | 0.622 | 3,782 | 1,479 | 0.391 |
65 | 79,107 | 89,563 | 252,733 |
|
United States | Johnson & Johnson Co. |
Others
|
29 | 17 | 0.586 | 41 | 27 | 0.659 | 4,343 | 1,414 | 0.326 |
66 | 79,289 | 89,765 | 253,405 |
|
United States | Johnson & Johnson Co. |
Others
Biomarker Research | Drug Discovery | Single Cell Profiling | High Dimensional Biology Technologies | Computational Sciences | |
29 | 16 | 0.552 | 44 | 21 | 0.477 | 6,130 | 1,956 | 0.319 |
69 | 81,461 | 92,223 | 261,586 |
|
United States | Johnson & Johnson Co. |
Others
|
28 | 22 | 0.786 | 54 | 38 | 0.704 | 2,230 | 1,410 | 0.632 |
75 | 84,909 | 96,122 | 274,888 |
|
United States | Johnson & Johnson Co. |
Others
Healthcare Data Science | Drug Development | Real World Evidence | External Control Arms | |
27 | 24 | 0.889 | 40 | 34 | 0.850 | 3,622 | 2,238 | 0.618 |
77 | 86,696 | 98,142 | 282,042 |
|
United States | Johnson & Johnson Co. |
Others
|
27 | 19 | 0.704 | 49 | 36 | 0.735 | 3,630 | 1,225 | 0.337 |
82 | 88,007 | 99,648 | 287,181 |
|
United States | Johnson & Johnson Co. |
Others
|
27 | 15 | 0.556 | 32 | 16 | 0.500 | 5,380 | 897 | 0.167 |
A New and Different Feature!!!! University Subject Rankings in 12 subjects:Ranking and analysis of universities by subject in 12 fields such as health, engineering, natural sciences, education, business, economics, social sciences, etc. |
||||||||||||||||
84 | 88,627 | 100,345 | 289,205 |
|
United States | Johnson & Johnson Co. |
Others
|
27 | 7 | 0.259 | 56 | 4 | 0.071 | 2,158 | 160 | 0.074 |
86 | 90,274 | 102,186 | 295,331 |
|
United States | Johnson & Johnson Co. |
Others
Translation Informatics | |
26 | 22 | 0.846 | 32 | 30 | 0.938 | 4,172 | 1,874 | 0.449 |
87 | 90,393 | 102,320 | 295,960 |
|
United States | Johnson & Johnson Co. |
Others
|
26 | 21 | 0.808 | 49 | 44 | 0.898 | 2,470 | 1,471 | 0.596 |
89 | 91,054 | 103,070 | 298,556 |
|
United States | Johnson & Johnson Co. |
Others
|
26 | 20 | 0.769 | 37 | 29 | 0.784 | 3,339 | 2,534 | 0.759 |
90 | 91,951 | 104,091 | 302,275 |
|
United States | Johnson & Johnson Co. |
Others
biopolymers shape memory polymers | polymer nanocomposites | hydrogels | epoxies acrylic coatings | thermotropic polymers | |
26 | 17 | 0.654 | 66 | 36 | 0.545 | 3,517 | 1,258 | 0.358 |
93 | 94,221 | 106,642 | 311,307 |
|
United States | Johnson & Johnson Co. |
Others
|
25 | 23 | 0.920 | 37 | 32 | 0.865 | 2,010 | 1,451 | 0.722 |
95 | 95,454 | 108,028 | 315,561 |
|
United States | Johnson & Johnson Co. |
Others
Autoimmunity | Immunology | Microbiome | |
25 | 21 | 0.840 | 28 | 25 | 0.893 | 2,273 | 1,064 | 0.468 |
96 | 97,088 | 109,877 | 322,445 |
|
United States | Johnson & Johnson Co. |
Others
|
25 | 17 | 0.680 | 38 | 23 | 0.605 | 4,344 | 1,370 | 0.315 |
102 | 103,920 | 117,608 | 349,482 |
|
United States | Johnson & Johnson Co. |
Others
Clinical drug development | imaging and digital measurements | |
24 | 13 | 0.542 | 30 | 13 | 0.433 | 1,784 | 510 | 0.286 |
103 | 103,932 | 117,622 | 349,508 |
|
United States | Johnson & Johnson Co. |
Others
|
24 | 13 | 0.542 | 28 | 17 | 0.607 | 1,522 | 553 | 0.363 |
Only in AD Scientific Index !!!!Subject Rankings, University Subject Rankings, Citiation Rankings, i10 Productivity Rankings, Country Rankings, Detailed analyses of universities |
||||||||||||||||
108 | 107,560 | 121,708 | 363,532 |
|
United States | Johnson & Johnson Co. |
Others
|
23 | 18 | 0.783 | 31 | 30 | 0.968 | 2,968 | 930 | 0.313 |
112 | 110,700 | 125,250 | 376,132 |
|
United States | Johnson & Johnson Co. |
Others
|
22 | 22 | 1.000 | 34 | 33 | 0.971 | 7,528 | 6,630 | 0.881 |
114 | 111,944 | 126,642 | 380,800 |
|
United States | Johnson & Johnson Co. |
Others
inflammatory bowel diseases | pediatric drug development | Duchenne muscular dystrophy | |
22 | 20 | 0.909 | 31 | 28 | 0.903 | 2,789 | 1,559 | 0.559 |
123 | 114,527 | 129,517 | 390,373 |
|
United States | Johnson & Johnson Co. |
Others
patents | |
22 | 16 | 0.727 | 52 | 35 | 0.673 | 2,292 | 1,399 | 0.610 |
127 | 115,482 | 130,618 | 394,805 |
|
United States | Johnson & Johnson Co. |
Others
|
22 | 15 | 0.682 | 27 | 18 | 0.667 | 4,637 | 1,783 | 0.385 |
128 | 116,690 | 131,979 | 399,552 |
|
United States | Johnson & Johnson Co. |
Others
|
22 | 12 | 0.545 | 25 | 14 | 0.560 | 5,415 | 1,807 | 0.334 |
135 | 122,429 | 138,392 | 421,381 |
|
United States | Johnson & Johnson Co. |
Others
Antibody discovery | Immunology | Neurodegenerative disease | Protein homeostasis | |
21 | 15 | 0.714 | 22 | 18 | 0.818 | 2,903 | 1,224 | 0.422 |
138 | 124,222 | 140,402 | 428,861 |
|
United States | Johnson & Johnson Co. |
Others
|
21 | 10 | 0.476 | 23 | 11 | 0.478 | 3,342 | 442 | 0.132 |
141 | 127,579 | 144,111 | 441,659 |
|
United States | Johnson & Johnson Co. |
Others
|
20 | 17 | 0.850 | 26 | 25 | 0.962 | 3,492 | 1,216 | 0.348 |
142 | 127,715 | 144,261 | 442,055 |
|
United States | Johnson & Johnson Co. |
Others
Comparative Effectiveness Research | Medicine | Epidemiology | Bio-statistics | pharmacoepidemiology | |
20 | 17 | 0.850 | 25 | 21 | 0.840 | 1,519 | 1,125 | 0.741 |